Cassava Sciences | PTIE - Kreditur Perdagangan





Kreditur Perdagangan Perubahan Tanggal
Abbott USD 4.24B 117M 2025-12
Amgen USD 19.52B 1.37B 2026-03
Biogen USD 358.5M 73.5M 2026-03
Cara Therapeutics USD 3.22M 859K 2025-12
Cassava Sciences USD 41.65M 4.44M 2025-12
Eisai JPY 75.89B 9.6B 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Geron USD 12.72M 1.46M 2026-03
J&J USD 10.46B 1.53B 2026-03
Merck USD 3.86B 541M 2026-03
Novartis USD 4.32B 134M 2026-03
Novavax USD 16.1M 8.48M 2026-03
Pfizer USD 4.51B 734M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12